P
Paquita Nurden
Researcher at National Institute for Health Research
Publications - 152
Citations - 9552
Paquita Nurden is an academic researcher from National Institute for Health Research. The author has contributed to research in topics: Platelet & Platelet activation. The author has an hindex of 46, co-authored 151 publications receiving 8629 citations. Previous affiliations of Paquita Nurden include French Institute of Health and Medical Research & University of Bordeaux.
Papers
More filters
Journal ArticleDOI
Autologous platelets as a source of proteins for healing and tissue regeneration
TL;DR: The aim is to discuss the ways in which platelets may provide such unexpected beneficial therapeutic effects in clinical situations requiring rapid healing and tissue regeneration.
Journal ArticleDOI
Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture.
Eduardo Anitua,Isabel Andia,Mikel Sánchez,Juan Azofra,M del Mar Zalduendo,Maria de la Fuente,Paquita Nurden,Alan T. Nurden +7 more
TL;DR: It is suggested that administering autologous platelet‐rich clots may be beneficial to the treatment of tendon injuries by inducing cell proliferation and promoting the synthesis of angiogenic factors during the healing process.
Journal ArticleDOI
New insights into and novel applications for platelet-rich fibrin therapies
TL;DR: The therapeutic use of autologous platelet-rich plasma is highlighted and some of the obstacles and challenges that need to be addressed to maintain progress in this field are discussed.
Journal ArticleDOI
Platelets and wound healing.
TL;DR: The therapeutic use of platelets in a fibrin clot has a positive influence in clinical situations requiring rapid healing and is reviewed in situations where the use of autologous platelets accelerates healing.
Journal ArticleDOI
Compound inheritance of a low-frequency regulatory SNP and a rare null mutation in exon-junction complex subunit RBM8A causes TAR syndrome
Cornelis A. Albers,Cornelis A. Albers,Cornelis A. Albers,Dirk S. Paul,Harald Schulze,Kathleen Freson,Jonathan Stephens,Jonathan Stephens,Peter A. Smethurst,Peter A. Smethurst,Jennifer Jolley,Jennifer Jolley,Ana Cvejic,Ana Cvejic,Ana Cvejic,Myrto Kostadima,Paul Bertone,Martijn H. Breuning,Najet Debili,Panos Deloukas,Rémi Favier,Janine Fiedler,Janine Fiedler,Catherine M. Hobbs,Catherine M. Hobbs,Ni Huang,Matthew E. Hurles,Graham Kiddle,Graham Kiddle,Ingrid P.C. Krapels,Paquita Nurden,Claudia A. L. Ruivenkamp,Jennifer G. Sambrook,Jennifer G. Sambrook,K Smith,K Smith,Derek L. Stemple,Gabriele Strauss,Chantal Thys,Christel Van Geet,Ruth Newbury-Ecob,Ruth Newbury-Ecob,Willem H. Ouwehand,Willem H. Ouwehand,Willem H. Ouwehand,Cedric Ghevaert,Cedric Ghevaert +46 more
TL;DR: The first human disorder, thrombocytopenia with absent radii (TAR), is described, caused by deficiency in one of the four EJC subunits, and data implicate Y14 insufficiency and, presumably, an EJC defect as the cause of TAR syndrome.